Cancer Institute A national cancer institute
designated cancer center

Cancer Prevention and Control Program

Developmental Research Awards Calendar News News
 Disruption of immune-system pathway key step in cancer progression
 

Overview

Dr Kim Rhoads on
Racial disparities in cancer outcomes
Paul Costello interview:  U-Tunes Link

The Cancer Prevention and Control Program focuses on reducing the cancer incidence, cancer-related morbidity, and mortality in men and women across the age spectrum through research aimed at identifying efficient intervention techniques. The Stanford Prevention Research Center (SPRC), Stanford Center for Integrative Medicine, Stanford Center on Stress and Health, Cancer Center Shared Resources, and the Cancer Prevention Institute of California (formerly NCCC) provide extensive networks with community organizations and physician groups, including many that work with under served populations, strengthen the Cancer Prevention and Control portion of the Population Sciences research program. Leaders are Dr Marcia Stefanick and Dr David Spiegel.
Dr Stefanick focuses on prevention trials of lifestyle and hormone interventions, while Dr Spiegel focuses on quality of life and psychosocial support of cancer patients. Dr Stefanick has conducted several major randomized controlled trials of lifestyle (physical activity, diet, and weight loss) interventions. These studies involve recruitment, interventions, data collection, and participant retention over many years of follow-up with thousands of men and women across a wide age range, including the largest and longest (average 8-year) diet trial ever conducted, i.e. the Women's Health Initiative (WHI) Diet Modification Trial of postmenopausal women.
Dr Spiegel's research has focused on the development and evaluation of effective psychosocial support for women with metastatic breast cancer, and on the physiology linking stress to the rate of disease progression. Recently he has shown that abnormal diurnal variation of cortisol predicts significantly earlier mortality with breast cancer, a finding which was the basis of a Program Project grant funded by NCI and NIA on Stress, the HPA and Health in Aging. His group has published randomized controlled trial evidence that intensive group psychotherapy reduces traumatic stress symptoms, distress, and pain, and increases survival. His research has provided an empirically proven model for provision of psychosocial support for women with breast cancer.  

Cancer Prevention and Control Program Leaders:
Marcia Stefanick, PhD - Leader
David Spiegel, MD - Co-Leader

Cancer Prevention and Control Program Members:
Members Listing

 

This document was last modified: Monday, 24-Feb-2014 23:32:51 PST

Stanford Medicine Resources:

Footer Links: